Nattokinase 50 mg
Japanese fibrinolytic enzyme for reducing cardiovascular risk
Availability : is available
Certificate of Analysis
Sudden development of clots in the arteries is the third leading cause of death and the principal cause of disability among adults in developed countries. While the blood's capacity to coagulate is essential to survival, when clots form in arteries narrowed by plaque (a thrombosis) or when they travel to other vessels (an embolism) the consequences can be catastrophic. In some cases, vascular accidents can cause serious and irreversible damage to limbs or areas of the brain deprived of blood for a given period.
Nattokinase is a unique and powerful systemic enzyme obtained by fermenting non-GMO soya beans. Around twenty years ago, a Japanese research team led by Dr Hiroyuki Sumi discovered its fibrinolytic activity (regulates clot formation) in vitro. This activity was subsequently confirmed by several animal and in vivo studies. Fibrinolytic activity and blood mobility showed significant improvements. Several other cardiovascular parameters, such as HDL and LDL cholesterol levels, also improved.
Nattokinase is natural nutrient, free from side effects, the efficacy of which has been confirmed by animal and human studies. Anyone with a higher than average cardiovascular risk should include it, along with Co-enzyme Q10, in their preventive supplementation regime.
Each softgel contains 50 mg nattokinase corresponding to 650 FU (fibrinolytic activity units).
Recommended use: Take two to four softgels a day, or as advised by your therapist.
Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet. Keep out of childrens' reach. Store away from direct light, heat and humidity. As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.